Biotech

Sort by Latest
What the replication crisis means for AI and drug discovery
Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how reproducible their work was. This question goes to the very core of the scientific method, and has formed the backbone of countless clinical trials. As it turns out, the results were pretty bleak. More than 70% of those surveyed tried and failed to reproduce the results of another scientist, and 73% said that only around half of the papers in their field can be trusted. This phenomenon, colloquially...
May 4, 2023
2 min read
Final(ly) Rules of Procedure of the UPC
Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations,...
July 18, 2022
1 min read
To opt-out or not? The UPC will change the rules of the game in the European patent field possibly as soon as next fall
Early this year it became clear that the long-pending reform of the European patent system is finally...
June 1, 2022
7 min read
The UPC Committees rule!
Start of the Provisional Application Phase and first committee meetings The Provisional...
April 7, 2022
12 min read
The Return of Biosimilar Substitution in France
Every year the Social Security Financing Law for 2022 (LFSS 2022) introduces several measures resulting...
March 28, 2022
3 min read
International Comparative Legal Guide to Digital Health 2022
Our Life Sciences IP, Regulatory and Data Protection experts Sally Shorthose, Toby Bond, Emma Drake and...
March 17, 2022
1 min read
Impact of Brexit on Artificial Intelligence in Healthcare
AI developments in the UK The UK is starting to uncover significant opportunities...
February 5, 2021
5 min read